S&P 500   3,755.81 (-2.44%)
DOW   30,334.65 (-1.95%)
QQQ   321.10 (-2.28%)
AAPL   142.19 (-0.68%)
MSFT   232.40 (+0.03%)
FB   272.97 (-3.22%)
GOOGL   1,824.41 (-4.38%)
AMZN   3,258.50 (-2.03%)
TSLA   875.32 (-0.88%)
NVDA   517.88 (-3.63%)
BABA   261.98 (-1.48%)
CGC   38.05 (+7.12%)
GE   10.78 (-4.52%)
MU   75.51 (-5.03%)
AMD   89.35 (-5.66%)
NIO   57.62 (-4.46%)
T   29.09 (-2.22%)
F   10.81 (-3.40%)
ACB   11.46 (+7.40%)
BA   193.30 (-4.34%)
DIS   162.97 (-3.89%)
NFLX   533.11 (-5.13%)
GILD   65.66 (-1.56%)
S&P 500   3,755.81 (-2.44%)
DOW   30,334.65 (-1.95%)
QQQ   321.10 (-2.28%)
AAPL   142.19 (-0.68%)
MSFT   232.40 (+0.03%)
FB   272.97 (-3.22%)
GOOGL   1,824.41 (-4.38%)
AMZN   3,258.50 (-2.03%)
TSLA   875.32 (-0.88%)
NVDA   517.88 (-3.63%)
BABA   261.98 (-1.48%)
CGC   38.05 (+7.12%)
GE   10.78 (-4.52%)
MU   75.51 (-5.03%)
AMD   89.35 (-5.66%)
NIO   57.62 (-4.46%)
T   29.09 (-2.22%)
F   10.81 (-3.40%)
ACB   11.46 (+7.40%)
BA   193.30 (-4.34%)
DIS   162.97 (-3.89%)
NFLX   533.11 (-5.13%)
GILD   65.66 (-1.56%)
S&P 500   3,755.81 (-2.44%)
DOW   30,334.65 (-1.95%)
QQQ   321.10 (-2.28%)
AAPL   142.19 (-0.68%)
MSFT   232.40 (+0.03%)
FB   272.97 (-3.22%)
GOOGL   1,824.41 (-4.38%)
AMZN   3,258.50 (-2.03%)
TSLA   875.32 (-0.88%)
NVDA   517.88 (-3.63%)
BABA   261.98 (-1.48%)
CGC   38.05 (+7.12%)
GE   10.78 (-4.52%)
MU   75.51 (-5.03%)
AMD   89.35 (-5.66%)
NIO   57.62 (-4.46%)
T   29.09 (-2.22%)
F   10.81 (-3.40%)
ACB   11.46 (+7.40%)
BA   193.30 (-4.34%)
DIS   162.97 (-3.89%)
NFLX   533.11 (-5.13%)
GILD   65.66 (-1.56%)
S&P 500   3,755.81 (-2.44%)
DOW   30,334.65 (-1.95%)
QQQ   321.10 (-2.28%)
AAPL   142.19 (-0.68%)
MSFT   232.40 (+0.03%)
FB   272.97 (-3.22%)
GOOGL   1,824.41 (-4.38%)
AMZN   3,258.50 (-2.03%)
TSLA   875.32 (-0.88%)
NVDA   517.88 (-3.63%)
BABA   261.98 (-1.48%)
CGC   38.05 (+7.12%)
GE   10.78 (-4.52%)
MU   75.51 (-5.03%)
AMD   89.35 (-5.66%)
NIO   57.62 (-4.46%)
T   29.09 (-2.22%)
F   10.81 (-3.40%)
ACB   11.46 (+7.40%)
BA   193.30 (-4.34%)
DIS   162.97 (-3.89%)
NFLX   533.11 (-5.13%)
GILD   65.66 (-1.56%)
Log in
OTCMKTS:ADDXF

Addex Therapeutics Stock Forecast, Price & News

$1.65
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.65
Now: $1.65
$1.65
50-Day Range
$1.65
MA: $1.65
$1.65
52-Week Range
$1.65
Now: $1.65
$1.65
VolumeN/A
Average VolumeN/A
Market Capitalization$43.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.44
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

MarketRank

Overall MarketRank

0.56 out of 5 stars

Medical Sector

1378th out of 1,926 stocks

Pharmaceutical Preparations Industry

614th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ADDXF
CUSIPN/A
CIKN/A
Phone41 22 884 1555
Employees19
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$43.51 million
Next Earnings DateN/A
OptionableNot Optionable
$1.65
0.00 (0.00 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADDXF News and Ratings via Email

Sign-up to receive the latest news and ratings for ADDXF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Addex Therapeutics (OTCMKTS:ADDXF) Frequently Asked Questions

How has Addex Therapeutics' stock been impacted by COVID-19?

Addex Therapeutics' stock was trading at $1.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ADDXF stock has decreased by 2.9% and is now trading at $1.65.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Addex Therapeutics?

Wall Street analysts have given Addex Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Addex Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Addex Therapeutics' key competitors?

Who are Addex Therapeutics' key executives?

Addex Therapeutics' management team includes the following people:
  • Mr. Timothy Mark Dyer, Co-Founder, CEO & Director (Age 53)
  • Dr. Roger G. Mills M.D., Chief Medical Officer & Director (Age 64)
  • Mr. Lenaic Teyssedou, Head of Fin. (Age 36)
  • Dr. Jean-Philippe Rocher Ph.D., Head of Discovery - Chemistry (Age 62)
  • Dr. Robert Lutjens, Head of Discovery - Biology (Age 53)
  • Dr. Werner Henrichi Ph.D., Consultant (Age 78)

What is Addex Therapeutics' stock symbol?

Addex Therapeutics trades on the OTCMKTS under the ticker symbol "ADDXF."

How do I buy shares of Addex Therapeutics?

Shares of ADDXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Addex Therapeutics' stock price today?

One share of ADDXF stock can currently be purchased for approximately $1.65.

How big of a company is Addex Therapeutics?

Addex Therapeutics has a market capitalization of $43.51 million. Addex Therapeutics employs 19 workers across the globe.

What is Addex Therapeutics' official website?

The official website for Addex Therapeutics is www.addextherapeutics.com.

How can I contact Addex Therapeutics?

The company can be reached via phone at 41 22 884 1555.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.